Table 1 Currently Approved Disease-Modifying Antirheumatic Drugs
From: Types of pain and their psychosocial impact in women with rheumatoid arthritis
1. Synthetic DMARDs | |
 Conventional Synthetic DMARDs | Methotrexate, Sulfasalazine, Leflunomide, Hydroxychloroquine |
 Targeted Synthetic DMARDs | Tofacitinib, Baricitinib |
2. Biologic DMARDs | |
 TNF-inhibitors | Etanercept, Adalimumab, Infliximab, Golimumab, Certolizumab |
 Anti-B-cell | Rituximab |
 Anti-T-cell | Abatacept |
 Anti-IL-6 receptor | Tocilizumab, Sarilumab |